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As the sulfonamides are well known for their bacteriostatic pro-
perties against bacteria and several organic arsenic compounds have
a good parasiticidal activity against trypanosomes and spirochetes,
some compounds representing a combination of sulfonamides and
arsenicals have been synthesized.
The purpose was to combine the advantages of these two impor-
tant classes of chemotherapeutics and to get cornpounds with a more
extensive working field.
In the scheme, added to p. 106, a survey is given of the new com-
pounds  syn thes ized ;  the  numbers  1 ,2 ,3 ,  4 ,6  and  12  have  been
described previously.
The arsenic compounds have been prepared by reduction of the
corresponding arsonic acids with Na2SrOu in neutral solut ion; the
arsonic acids were made by interaction of AsCl3 with the corres-
ponding diazonium compounds. In two cases the arsenoxides were
prepared by reduction of the arsonic acids with sulphur dioxide.
The compounds synthesized were tested for chemotherapeutic
propert ies in three ways:
1) In order to investigate the activi ty of the compounds against
pneumococci in vivo, a standard dose was administered by mouth to
mice infected with pneumococci. By comparing the progress of the
septicemia in a treated mouse with that in an untreated mouse, it
lwas possible to deduce the activity of the compounds tested. These
compounds (Nr .  4 ,  5 ,9,  10,  21,23 and 24)  d id not  show any
activity.
2) A number of the compounds were tested for act ivi ty against
pneumococci in vitro. In part icular a , ,sulfonamide activi ty" ( i .e. a
bacteriostat ic act ion in vitro annihi lated by p-aminobenzoic acid
(p.a.b.) was looked for. The bacteriostat ic act ivi ty oÍ a compound
was measured by the time, in which a culture of pneumococci in
ascitic broth, in presence of the compound, becomes opaque, in
comparison with a control test. In case of bacteriostasis the influ-
ence of extra added p.a.b. was studied in a separate test; when
normal growth occurred in this last test, the compound possessed
sulfonamide activitv.
106
The activity against pneumococci (P) is indicated in the general
scheme by the following marks:
Po : no activity, P + - activity, P * s - sulfonamide activity.
The number between parentheses indicates the table in which the
experimental results are mentioned.
3) To investigate the activity against trypanosomes, infected
mice were intraveneously injected with a certain amount of the com-
pound concerned. If the compound had no activity, the mouse died
after 3 days; in the other case the mouse survived the infection. The
blood was controlled during eight days atter disappeaÍance of the
trypanosomes.
In the table To indicates that the compound has no activity
against rypanosomes and T + that the mouse survived the infection.
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